地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:18995651644
邮箱:sales@amyjet.com
<艾美捷科技代理CSCRIE Corporation品牌全系列产品
CSCRIE Corporation成立于2020年3月,公司致力于解决生命科学领域研究人员面临的问题,通过运用多年来积累的精密冲压技术、胶带与薄膜层压技术以及激光微加工技术,为生命科学市场提供各类产品。此外,CSCRIE公司还承接原创细胞培养板以及微流控芯片等带有微孔与微槽的产品的试制与开发。CSCRIE公司的产品包括样品过滤、标签与密封(多种应用),特种微孔板等产品。

▍CSCRIE产品线
● 样品过滤
CSCRIE的离心管用密封式滤器和96孔微孔板滤器可助您快速完成样品过滤。此外,其底部带滤网的96孔或384孔微孔板非常适合高通量筛选。
| 产品名称 | 产品描述 |
| Mesh seal for sample filtration (for 1.5 mL and 5 mL tubes) | This seal type mesh (strainer) is designed for rapid sample filtration on 1.5 mL and 5 mL tubes. |
| Mesh seal for sample filtration (for 15 mL tube) | This seal type mesh (strainer) is designed for rapid sample filtration on 15 mL tube. |
| Mesh seal for sample filtration (for 50 mL tube) | This seal type mesh (strainer) is designed for rapid sample filtration on 50 mL tube. |
| Mesh seal for sample filtration (for 96 well plate) | This seal type mesh (strainer) is designed for rapid sample filtration on 96 well plate. |
| Mesh bottom filtration plate (96- & 384-well plate) | This mesh bottom filtration plate is designed for rapid and highthrouput sample filtration from 96- or 384-well plate by centrifuge. |
● 标签与密封(多种应用)
| 产品名称 | 产品描述 |
| Sealing Film for real-time PCR | 低自体荧光压敏 PCR 板密封膜,兼容 PCR 和实时荧光定量 PCR (real-time PCR)。经 γ 射线灭菌,具备良好的耐热性(-20℃ 至 110℃)。 |
| Hydrophobic PDMS Sheet (Ultra-thin type) | 超薄高精度疏水性 PDMS(聚二甲基硅氧烷)薄膜,专注于活菌、活细胞及 DNA 的分析与培养。 |
| Hydrophilic PDMS Sheet | 具有持久亲水性的 PDMS 片材,适用于多种研究应用。 |
| Microplate note seal | 这是一款独特的密封膜,可在 96 孔微孔板上直接书写文字。 |
| Anti-Frost Label Protector | 防冻标签保护膜,可全面保护样品管上的标记,例如防霜冻、防乙醇等。 |
| Microplate seal for 96-well (cutting off type) | 微孔板封膜,可沿每行(8孔)的压痕线切割,便于在样本注入期间及之后反复开合。 |
● 特种微孔板
<| 产品名称 | 产品描述 |
| Microplate without bottom plate | 该微孔板无孔底部分,可根据研究应用需求在底部结合任意材料。其产品系列包括 6 孔、24 孔、96 孔及 384 孔规格。 |
● 其他产品
<| 产品名称 | 产品描述 |
| CS Mouse Wound Splint | CS 小鼠伤口夹板在与皮肤接触侧设有胶带层,因此固定夹板时无需额外使用粘合剂或胶水,与传统夹板相比,固定操作更便捷。 |
| CS IHC-Fencing Seal | 这是一种环绕载玻片上组织切片的疏水密封结构,可防止抗体、磷酸盐缓冲液(PBS)等试剂在组织标本上发生外溢或混合。 |

艾美捷科技代理T&T scientific品牌。
T&T Scientific 是一家专注于药物纳米医药制剂研发和制造的技术与服务公司。T&T Scientific 拥有三大核心部门:1) 合同研究、开发和 cGMP 制造;2) 制造平台全覆盖技术(供内部使用或销售);3) 脂质纳米颗粒制剂的发现、优化和技术开发。T&T Scientific 的质量体系由质量团队和电子质量系统(Qualio)管理。T&T Scientific 的质量部门确保药品质量以及技术转移过程的质量控制。T&T Scientific提供 PEG 化磷脂、常规磷脂、脂质体挤出器。
" data-original="http://antylia.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理T&T scientific品牌"> 艾美捷科技代理T&T scientific品牌
<艾美捷科技代理Gelomics品牌全系列产品
Gelomics专注于实现体外人体组织模型的生长,核心在于创新的3D细胞培养解决方案。这种技术模拟了人体组织的真实生长环境,相较于传统的细胞培养方式更为先进和贴近人体实际情况。团队由经验丰富的专业人士组成,他们具备深厚的专业知识和多年的行业经验,致力于推动公司通过3D细胞培养技术实现改变药物发现的愿景,为公司的技术研发和战略发展提供有力支持。所研究的高纯度、可调谐的 GelMA 提供了生物活性和机械控制的最佳平衡,使其成为生物医学研究和再生医学的绝佳选择。甲基丙烯酰明胶 (GelMA) – 冷水鱼皮,具有以下特征:
● 高度可调:能够精确控制刚度、孔隙率和退化等关键参数。GelMA可以根据不同的研究或应用需求进行定制化调整,满足多样化的实验和生产要求。
● 支持细胞活力和功能:为细胞的附着、增殖和分化提供了符合生物学要求的微环境。这对于细胞的生长和功能表达至关重要,有助于模拟体内真实的细胞生长环境,提高细胞培养的效果和质量。
● 与3D生物打印兼容:既可以单独使用,也能与其他生物材料一起使用,用于创建定制的细胞外基质(ECM),应用于生物制造和组织工程领域。

▍Gelomics产品列表
| 分类 | 品名 | 货号 |
| Gelatin Methacryloyl (GelMA) | Gelatin Methacryloyl (GelMA) – Bovine Bone | SKU0013 |
| Gelatin Methacryloyl (GelMA) | Gelatin Methacryloyl (GelMA) – Bovine Skin | SKU0024 |
| Gelatin Methacryloyl (GelMA) | Gelatin Methacryloyl (GelMA) – Bovine Bone | SKU0013 |
| Gelatin Methacryloyl (GelMA) | Gelatin Methacryloyl (GelMA) – Porcine Skin | SKU0010 |
| LAP - Photoinitiator Powder | Visible Light Photoinitiator | SKU0021 |
| LunaCrosslinker™ | LunaCrosslinker™ – Visible Light Crosslinking | - |
| LunaGel™ - Cell Recovery Kit | LunaGel™ - Cell Recovery Kit | SKU0015 |
| LunaGel™ System | LunaCrosslinker™ – Visible Light Crosslinking | - |
| LunaGel™ System | LunaGel™ Ultrapure GelMA – Photocrosslinkable Extracellular Matrix | SKU0018 |
| LunaGel™ System | LunaGel™ Bovine Bone – Photocrosslinkable Extracellular Matrix | SKU0009 |
| LunaGel™ System | LunaGel™ Bovine Skin – Photocrosslinkable Extracellular Matrix | SKU0020 |
| LunaGel™ System | LunaGel™ Cold Water Fish Skin – Photocrosslinkable Extracellular Matrix | SKU0011 |
| LunaGel™ System | LunaGel™ Porcine Skin – Photocrosslinkable Extracellular Matrix | SKU0012 |

艾美捷科技代理Sorachim品牌。
Sorachim公司提供诊断试剂专用酶:脂肪酶、过氧化物酶、尿酸酶,辅酶:NADH、NADPH、NADP;底物:TMB、双甘氨肽等 IVD 行业专用试剂。Sorachim 是一家专注于为制药、生物技术、化妆品和食品行业提供高质量化学原料和定制化解决方案的公司。公司成立于 1986 年,总部位于法国,凭借其广泛的产品组合、严格的质量控制和卓越的客户服务,已成为欧洲化学原料领域的重要供应商之一。Sorachim 的产品广泛应用于药物开发、化妆品配方、食品添加剂和工业应用等领域,包括:
制药原料:Sorachim 提供用于药物开发的化学原料,包括活性药物成分(API)、中间体、辅料和溶剂。
化妆品原料:提供用于化妆品配方的化学原料,如乳化剂、增稠剂、防腐剂和功能性添加剂。
食品添加剂:提供用于食品工业的化学原料,如乳化剂、稳定剂、防腐剂和香料。
工业化学品:公司为工业应用提供特种化学品,如表面活性剂、溶剂、涂料和油墨添加剂。
<< " data-original="http://antylia.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Sorachim品牌"> 艾美捷科技代理Sorachim品牌

Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括:
Array Tomography
Model Organisms
Disease Targets
产品列表:
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |

艾美捷科技代理Novocib品牌全系列产品
Novocib是一家成立于2005年的生物技术公司,专注于核苷酸代谢领域。公司开发了一系列用于细胞、食品和饲料原料中核苷酸分析的创新产品与服务,包括:全谱核苷酸分析服务、核苷酸酶检测试剂盒,核苷酸代谢纯化活性酶以及富含核苷酸的新产品和原料开发协助。

▍Novocib产品线
● 核苷酸分析:
包含全谱核苷酸分析,其涵盖杂环碱基、核苷、核苷酸以及核酸(DNA 和 RNA);酵母提取物中核苷、5'-核苷酸及核酸分析以及食品或饲料原料中嘌呤,嘧啶分析。
| 货号 | 品名 |
| #S1200-03 | Yeast Extract Nucleotides Analysis |
| #S1200-04 | Cellular Nucleotides Analysis |
| #S1200-05 | Nucleic acid RNA and DNA quantification by HPLC-UV analysis |
| #S1200-06 | HPLC-UV analysis for purines |
● PRECICE®一步法试剂盒:
预置精确定量的酶、缓冲液、辅因子及底物,浓度均为最佳配比;采用 96 孔微孔板规格;便捷省时,避免潜在操作误差。
| 品名 | 中文名称 | 货号 | 规格 |
| PRECICE® HPRT Assay Kit | 次黄嘌呤磷酸核糖基转移酶检测试剂盒 | #K0709-01-2 | 10 ml, 24 analyses (8 samples in triplicate) |
| PRPP-S Assay Kit | 磷酸核糖焦磷酸合成酶活性检测试剂盒 | #K0709-04-2 | 10 mL of reaction mixture (half 96-well plate) |
| Ampda Assay Kit | 腺苷酸脱氨酶检测试剂盒 | #K0709-05-1 | 12 analyses (5 ml reaction buffer) |
| Ampda Assay Kit | 腺苷酸脱氨酶检测试剂盒 | #K0709-05-2 | 24 analyses (10 ml reaction buffer) |
| Itp Ase Assay Kit | 肌苷三磷酸焦磷酸酶活性检测试剂盒 | #K0709-06-2 | 10 mL of reaction mixture (half 96-well plate) |
| Adk Phosphorylation Assay Kit | 腺苷酸激酶检测试剂盒 | #K0507-02 | 1 plate (96 assays) |
| Dck Phosphorylation Assay Kit | 脱氧胞苷激酶检测试剂盒 | #K0307-01 | 1 plate (96 assays) |
| Adk Assay Kit | 腺苷酸激酶检测试剂盒 | #K0507-01.01 | 1 plate (96 assays) |
| Adk Assay Kit | 腺苷酸激酶检测试剂盒 | #K0507-01.05 | 5 plates (5 x 96 assays) |
| Phosphatase Assay Kit | 磷酸酶通用检测试剂盒 | #K0211-01 | 1 plate (96 assays) |
● 活性纯化酶制剂:
核苷激酶;嘌呤代谢酶;支持微量至批量订购
| 品名 | 中文名称 | 货号 | 规格 |
| Human IMPDH, Type II | 肌酐一磷酸脱氢酶2 | #E-Nov1 | 50 mU;100 mU;250 mU |
| Human Recombinant Pnp | 人嘌呤核苷酸磷酸化酶 | #E-Nov2 | 20 Units;40 Units;120 Units |
| Recombinant Deoxycytidine Kinase | 脱氧胞苷激酶 | #E-Nov3 | 500 mUnits;2 Units |
| Human Ump Cmp Kinase | 胞质型 UMP-CMP 激酶 | #E-Nov4 | 1 Unit;5 Units |
| Recombinant Adenosine Kinase | 人腺苷酸激酶 | #E-Nov5 | 100 mUnits;200 mUnits;500 mUnits |
| Human cytosolic 5'-nucleotidase II (cN-II) | 5'-核苷酸酶 II | #E-Nov6 | 50 mUnits;150 mUnits |
| Bacterial Recombinant Impdh | 肌苷一磷酸脱氢酶 | #E-Nov7 | 50 mUnits |
| Bacterial FMN-reductase from Escherichia coli (Fre) | FMN 还原酶 | #E-Nov8 | 25 Units;50 Units;100 Units |
| Human Recombinant Hgprt | 人次黄嘌呤磷酸核糖基转移酶 | #E-Nov9 | 100 mUnits - 4 tubes with 25 mUnits each |
| Highly Pure Bacterial Luciferase | 细菌荧光素酶 | #E-Nov10 | 1 mg;2 mg;5 mg |
<艾美捷科技代理Amid Biosciences品牌全系列产品
Amid Biosciences是一家专注于生命科学研究和相关产品开发与制造的品牌,在蛋白质工程和酶开发、蛋白质表达和纯化等领域具备核心优势,尤其擅长利用细菌(如大肠杆菌、枯草芽孢杆菌)、酵母系统以及克隆试剂,为学术、工业和政府实体提供蛋白质表达工具。Amid Biosciences公司致力于帮助生物医学研究人员节省时间和成本,以实现研究目标,并以具有竞争力的价格提供高质量产品。公司产品线包括:生物素化工具和链霉亲和素、RAS 蛋白、鞘脂激活蛋白、噬菌体展示感受态细胞、感受态大肠杆菌细胞、炎症反应蛋白、磁性纳米颗粒、改性琼脂糖树脂、核酸染料和蛋白质可视化、质粒、聚合酶和PCR、蛋白酶、蛋白质表达载体、重组蛋白、RNA合成与修饰。

▍Amid Biosciences产品线
● 生物素化工具和链霉亲和素:提供高质量的重组BirA生物素连接酶、链霉亲和素和链霉亲和素荧光偶联物,以及用于蛋白质表达和体内生物素化的BL21 (λDE3) pBirA菌株。
● RAS蛋白:Amid Biosciences提供广泛的重组生物素化和非生物素化KRAS蛋白,以及参与KRAS调节的关键生物分子,支持药物发现和医学研究。
● 感受态大肠杆菌细胞:用于分子克隆、DNA文库构建、噬菌体展示、重组蛋白表达和诱变的必要工具。Amid Biosciences提供多种用于体内生物素化的菌株,以及高效化学感受态和电感受态大肠杆菌细胞。
● 噬菌体展示感受态细胞:用于高通量文库筛选的噬菌体展示技术,适用于克隆、亚克隆和蛋白质表达。Amid Biosciences提供化学和电化学两种形式的高效噬菌体展示大肠杆菌细胞。
● 鞘脂激活蛋白/皂苷:皂苷或鞘脂激活蛋白(SAP)是存在于溶酶体中的小非酶糖蛋白,具有多种应用,包括脂质代谢研究、药物输送系统、癌症治疗等。
● 炎症反应蛋白:炎症反应涉及复杂的细胞和介质网络,包括细胞因子和可溶性受体。了解炎症反应途径和分子机制对预防和治疗炎症性疾病非常重要。
● 磁性纳米颗粒:用于捕获、分离或纯化细胞、蛋白质、抗体和核酸等靶标。Amid Biosciences提供多种功能化磁性颗粒和配体。
● 改性琼脂糖树脂:用于酶和抗体的亲和纯化,Amid Biosciences提供高容量醛琼脂糖珠和链霉亲和素琼脂糖珠。
● 核酸染料和蛋白质可视化:提供ZicherGreen和ZicherRed核酸安全凝胶染色剂,作为致突变溴化乙锭的替代品。这些染色剂是高灵敏度且环保的荧光核酸染料,用于检测琼脂糖和聚丙烯酰胺凝胶中的DNA和RNA。
● 质粒:提供一系列常见质粒,用于克隆实验和应用,例如蛋白质表达和基因表达。pUC18和pUC19质粒提供了克隆限制性内切酶产生的DNA片段的选项,由于体积小,能够成功克隆大DNA片段。
● 蛋白酶:提供重组TEV、HRV 3C、SenP2蛋白酶,用于在蛋白质纯化过程中去除亲和标签和融合伙伴。
● 蛋白质表达载体:细菌表达载体允许在大肠杆菌中快速表达和随后大规模、经济高效地生产重组蛋白。拥有许多专有的表达载体,用于有效的高水平重组蛋白表达。
● 重组蛋白:使用专有的表达和纯化技术来生产高纯度的高产量重组蛋白和酶。蛋白质集合包括链霉亲和素、BirA生物素连接酶、Lambda蛋白磷酸酶、HRV 3C蛋白酶、TEV蛋白酶等。
● RNA合成与修饰:提供一系列用于RNA研究的产品,包括用于合成和修饰的试剂。产品包括T7 RNA聚合酶、大肠杆菌聚(A)聚合酶、T4 RNA连接酶1和2、鼠RNA酶抑制剂。
▍Amid Biosciences部分产品列表
| 品名 | 规格 | 货号 |
| BL21(λDE3)pBirA Chemically Competent E.coli Cells for in vivo Biotinylation | 10x0.1 ml (20 reactions) | BLB-201 |
| BirA Biotin Protein Ligase, Recombinant | 100 ug | BBL-301 |
| High Capacity Streptavidin Agarose Beads | 1 mL | SA-101-1 |
| BirA Biotin Ligase, MBP-tag, Recombinant | 0.1 mg | MBBL-301 |
| BirA Biotin Ligase, GST-tag | 0.1 mg | BBL-G-301 |
| G12C KRAS(1-166), Biotinylated at the C-terminus | 0.1 mg | KRAS12C-B-C-301 |
| G12D KRAS (1-166), Biotinylated at the C-terminus | 0.1 mg | KRAS12D-B-C-301 |
| G12V KRAS(1-166), Biotinylated at the C-terminus | 0.1 mg | KRAS12V-B-C-301 |
| KRAS G12C Protein, Human, Recombinant, AviTag | 0.1 mg | KRAS12C-301 |
| KRAS G12D Protein, Human, Recombinant, AviTag | 0.1 mg | KRAS12D-301 |
| KRAS G12R Protein, Human, Recombinant, AviTag | 0.1 mg | KRAS12R-301 |
| KRAS G12R Protein, Human, Recombinant, Biotinylated | 0.1 mg | KRAS12R-B-301 |
| KRAS G12V Protein, Human, Biotinylated, Without a His-tag | 0.1 mg | KRAS12V-B-302 |
| KRAS G12V Protein, Human, Recombinant, AviTag | 0.1 mg | KRAS12V-301 |
| KRAS G13D Protein, Human, Recombinant, AviTag | 0.1 mg | KRAS13D-301 |
| KRAS Y96D Protein, Human, Recombinant, AviTag | 0.1 mg | KRAS96D-301 |
| KRAS Y96D Protein, Human, Recombinant, Biotinylated | 0.1 mg | KRAS96D-B-301 |
| MEK1 Protein, Human, Recombinant, Biotinylated | 0.05 mg | MEK1-B-301 |
| MEK2 Protein, Human, Recombinant, Biotinylated | 0.05 mg | MEK2-B-301 |
| Neurofibromin (NF1), Human, Recombinant | 0.05 mg | NF1-301 |
| PI3Kα-RBD Protein, Human, Biotinylated | 0.05 mg | PIK3A-B-301 |
| Raf1 RBD Protein, Human, Recombinant, Biotinylated | 0.1 mg | RAF1-B-301 |
| RalA Protein, Human, Recombinant, Biotinylated | 0.1 mg | RALA-B-301 |
| RalB Protein, Human, Recombinant, Biotinylated | 0.1 mg | RALB-B-301 |
| Rheb Protein, Human, Recombinant, Biotinylated | 0.1 mg | RHEB-B-301 |
| Wild Type KRAS (1-166) Protein, Biotinylated at the C-terminus | 0.1 mg | KRAS-B-C-301 |
| Wild Type KRAS Protein, Human, Biotinylated, Without a His-tag | 0.1 mg | KRAS-B-302 |
| Wild Type KRAS Protein, Human, Recombinant, AviTag | 0.1 mg | KRAS-301-1 |
| Saposin D, Human, Recombinant | 0.1 mg | SAPD-301-1 |
| Saposin C, Human, Recombinant | 0.1 mg | SAPC-302-1 |
| Phage Display SS320 Chemically Competent E. coli Cells | 10 X 0.1 ml (20 reactions) | SS320-201 |
| Phage Display ER2738 Chemically Competent E. coli Cells | 10 X 0.1 ml (20 reactions) | EREC-201 |
| Phage Display TG1 Chemically Competent E. coli Cells | 10 X 0.1 ml (20 reactions) | TG1-201 |
| Phage Display ER2738 Electrocompetent E. coli Cells | 10 X 0.05 ml (20 reactions) | EREC-201 |
| Phage Display TG1 Electrocompetent E. coli Cells | 10 X 0.05 ml (20 reactions) | ETG1-201 |
| Phage Display SS320 Electrocompetent E. coli Cells | 10 X 0.05 ml (20 reactions) | SS320EC-201 |

艾美捷科技代理Biosynth品牌。
Biosynth公司专注于碳水化合物、核苷和酶底物的化学领域;Biosynth公司在多肽领域也表现出色,涵盖从发现和优化到文库、GMP新化学实体(NCEs)和新抗原的各个环节;同时不断扩大用于生命科学研究的生物活性多肽、抗体、蛋白质、酶和试剂的产品范围。Biosynth公司定制单克隆和多克隆抗体生产,同时还提供用于诊断的关键试剂,包括病毒和细菌抗原、抗血清和血浆。Biosynth特色产品尤其推荐:生产诊断试剂用显色底物,如:5-溴-4-氯-3-吲哚显色底物、4-硝基苯基(pNP)、显色底物、4-甲基伞形酮(MU)显色底物等。
<< " data-original="http://antylia.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Biosynth品牌"> 艾美捷科技代理Biosynth品牌

艾美捷科技特约代理Athens Research & Technology产品。
Athens Research & Technology公司位于美国乔治亚州雅典市,从1986年以来一直致力于纯化高纯度,高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白,血小板蛋白、转铁蛋白、免疫球蛋白等。
Athens Research & Technology Inc. has been purifying human proteins and developing polyclonal antisera to those proteins since 1986. We specialize in highly pure, highly active human proteins. We routinely purify serine proteases, protease inhibitors, neutrophil enzymes, apolipoproteins, lipoproteins, platelet proteins, transferrins, immunoglobulins, and more. Researchers around the world have been purchasing these research reagents from us for more than twenty-five years. You'll see our products referenced in major scientific publications in studies of inflammation, coronary disease, autoimmune disease, cancer, Alzheimer's Disease, and so on.
Athens Research & Technology公司的主要产品包括:
Coagulation Factors
Enzymes & Inhibitors
Immunoglobulins
Lipoproteins & Apolipoproteins
Low Endotoxin Level Proteins
Milk & Platelet Proteins
Neutrophil Proteins
Transferrins & Apotransferrins
Transport/Other Proteins
All Human Proteins
All Animal Proteins
Antibodies
Assay Kits
" data-original="http://antylia.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Athens Research & Technology"> Athens Research & Technology
<艾美捷科技代理Protide Pharmaceuticals品牌全系列产品
Protide Pharmaceuticals, Inc.是一家专注于生物制药生产上游工艺的创新型公司。Protide Pharmaceuticals公司的核心产品为血清替代物,其核心价值在于提供高性能、化学成分明确、无动物来源的血清替代物和定制化培养基解决方案,帮助客户大幅减少生物制品生产过程中对胎牛血清或其他动物血清的依赖。,从而提高生物制品生产的效率、一致性、安全性和合规性。
除了血清替代物,Protide Pharmaceuticals公司也提供完整的、优化的无血清培养基配方,专门设计用于支持各种哺乳动物细胞系(如CHO, HEK293, Vero, MRC-5等)在生物反应器中进行高密度培养和高产率生产目标生物分子(如抗体、病毒载体、重组蛋白)。其产品应用于再生医学、肿瘤生物学、细胞生物能量学、肿瘤免疫学、转化医学、表观遗传学,胰岛细胞移植等领域。

▎Protide Pharmaceuticals产品线
● 血清替代品/生物制品生产培养基
Protide Pharmaceuticals的血清替代品通过提供优质、生物一致且功能性的环境,显著改善细胞的生理状态。所有血清替代品均配制成 50 倍浓缩液,这大大降低了成本,并改善了储存和供应链活动。Protide血清替代品不含:酚红、生长因子、类固醇激素、糖皮质激素、细胞粘附分子、生长因子、类固醇激素等物质,可以在其缺失或存在的情况下进行有效研究。细胞分泌的蛋白质可以在不受污染性血清成分干扰的情况下实现高度纯化。
| 品名 | 货号-规格 | 产品描述 |
| TCH™ | 3001-40ml;3002-100ml;3005-100ml | 本血清替代品主要用于人类细胞培养及细胞分泌蛋白的生产。TCH™ 在培养其他哺乳动物细胞时同样有效,且不含动物蛋白。其成分仅包含经热处理的人源蛋白(即人血清白蛋白、人转铁蛋白、重组人胰岛素)。 |
| VaxMax™ | 6004-100ml;6005-500ml;6006-1L | 100倍浓缩液是一种高性价比产品,可显著降低总体血清需求量。在MDBK、MDCK、Vero、CRFK及猪睾丸细胞培养中,使用VaxMax™已展现出显著的产量提升。兽用疫苗生产商已采用VaxMax™来增强生产,同时降低总体成本。VaxMax™通常与0.5%至1% 的血清配合使用。 |
| HemaPro™ | 3300-40ml;3303-100ml | 本产品为无血清添加剂,专为人祖细胞培养而设计。可有效用于癌症干细胞、诱导多能干细胞和间充质干细胞 的研究。不含:促红细胞生成素;重组生长因子。 |
| TM-235™ | 2001-40ml;2002-100ml;2005-500ml | 本血清替代品具有与TCM™类似的特性,但额外添加了适用于需要更高血清浓度(通常超过10%)的细胞类型的成分。TM-235™是一种成分明确且多用途的替代品。 |
| TCM™ | 1001-40ml;1002-100ml;1005-500ml | 本产品是一种通用型血清替代品,适用于多种物种来源的广泛细胞类型。TCM™是一种成分明确且多用途的血清替代品,可有效用于研究生长因子的影响以及蛋白质的生产。 |
● 低温保护剂
| 品名 | 货号-规格 | 产品描述 |
| Stemsol™ USP (DMSO) | PP1250-5ml;PP1300-10ml;PP1350-50ml;PP1400-100ml | 本产品为干细胞冻存溶液,适用于来源于脐带血、外周血、骨髓及其他生物组织和细胞的干细胞。 |
| pZerve™ | 5700-60ml;5720-20ml | pZerve™ 是一款独特的冻存溶液,不含 DMSO、胎牛血清或动物蛋白。本品为即用型,无需任何稀释或进一步处理。适用细胞类型包括:肥大细胞、树突细胞、间充质细胞、人转移性前列腺腺癌细胞、人结肠腺癌细胞,人转化胚肾细胞。 |
| Cellvation™ | 5001-60ml | Cellvation™ 是一款独特的冻存溶液,不含 DMSO 或胎牛血清。本品使用便捷,并能提供最佳的细胞复苏效果。在冷冻程序启动前,细胞可置于 Cellvation™ 中较长时间。本品为即用型,适用于无血清培养基或含血清培养基培养的细胞。 |
| MiCord™ 55% DMSO USP 5% Dextran USP | 1505-5ml;1500-7ml;;1700-10ml;1550-50ml;1600-100ml | 本产品为干细胞冻存溶液,适用于来源于脐带血、外周血、骨髓及其他生物组织和细胞的干细胞。 |
| 2-8CELLsius™ + DMSO,5% DMSO | PP338DM5-10ml;PP338DM5-100ml;PP338DM5-100B | 当与DMSO配合使用时,2-8CELLsius™可用作冻存液。2-8CELLsius™ + DMSO冻存液是一种细胞保护性、无蛋白溶液,含有生物稳定剂,可支持冻融后细胞的高存活率。其通过针对超低温下细胞生理学的创新方法,实现最佳的细胞复苏效果。不含:任何生长因子,激素以及抗生素。 |
| 2-8CELLsius™ + DMSO,10% DMSO | PP338DM10-10ml;PP338DM10-100ml;PP338DM10-100B;PP338DM10-1000B | |
| 2-8CELLsius™ + DMSO,20% DMSO | PP338DM20-100B;PP338DM20-1000B |
● 细胞处理
| 品名 | 货号-规格 | 产品描述 |
| 2-8CELLsius™ | PP338-100ml;PP338-500ml;PP338-1000;PP338-1000B | 即用型、平衡、细胞保护性、无蛋白溶液,含生物稳定剂,适用于:短期储存、再生医学、干细胞处理以及生物材料运输。 |
| Dextran 40 in 0.9% NaCl | PP1850-50ml;PP1840-1000ml;PP1880-250ml;PP1900-500ml | - |
| Dulbecco’s Phosphate Buffered Saline (10X) PBS | PBS210-500ml;PBS211-1000ml | 无钙镁储存条件:15-30°C;包装于PETG瓶;稳定性:至少6个月;无菌过滤 |
| Dulbecco’s Phosphate Buffered Saline (1X) PBS | PBS200-500ml;PBS201-1000ml | 无钙镁储存条件:15-30°C;包装于PETG瓶;稳定性:至少6个月;无菌过滤 |
| Hank’s Balanced Salt Solution (1X) HBSS | HS240-500ml;HS241-1000ml | 无钙镁配方:储存温度 4-8°C;无酚红配方;稳定性:至少6个月;含0.35克/升 碳酸氢钠;含1000毫克/升 D-葡萄糖;包装于 PETG 瓶,无菌过滤。cGMP 规范生产。 |
● CIT 胰岛细胞溶液
| 品名 | 货号-规格 |
| Cold Storage/Purification Stock Solution | 111098-1L |
| Phase I Solution | 060899-1L |
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18372041646
传真:18771149750
邮箱:sales@amyjet.com
0.239